ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

8-ニトロキノリン

8-Nitroquinoline

HCID 11830
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
607-35-2
標準SMILES
O=[N+]([O-])c1cccc2cccnc12
InChIKey
OQHHSGRZCKGLCY-UHFFFAOYSA-N
分子式
C9H6N2O2
平均分子量
174.16 g/mol
単同位体質量
174.04292743

名称と識別子

優先名称
8-Nitroquinoline
IUPAC
8-nitroquinoline
現地名
8-ニトロキノリン
英語名
8-Nitroquinoline
分子式
C9H6N2O2
分子量
174.16

名称と別名

8-NITROQUINOLINE607-35-2Quinoline, 8-nitro-MFCD000068068-Nitro-quinolineDTXSID6020985YWO6S88V4VCHEMBL167727NSC-346NSC3464msn8-NITRO QUINOLINE
名称をさらに表示
8-ニトロキノリン8‐ニトロキノリン8-ニトロキノリン, 98%NSC 346AKOS 214-038-NitroquinoL8-Nitrochinolin8-nitro-quinolin8-NitroquniolineQuinoline,8-nitro-8-Nitroquinoline>
8-Nitroquinoline, 98%WLN: T66 BNJ JNWDTXCID00985SCHEMBL949962SCHEMBL4049852SCHEMBL5558122SCHEMBL6449910SCHEMBL8487038

データベース識別子

CAS
607-35-2
PubChem CID
11830
DTXSID
DTXSID6020985
ChEMBL
CHEMBL167727
UNII
YWO6S88V4V
EC Number
210-135-9
Nikkaji
J2.987D

物性

構造計算による物性補完中

XLogP
1.4
極性表面積
58.7 Ų
水素結合供与体数
0
水素結合受容体数
3
回転可能結合数
0
重原子数
13
形式電荷
0
複雑度
202

実験および物理化学的性質

Chemical ClassesNitrogen Compounds -> Quinolines
SpringerMaterials PropertiesChemical shift
LogP · 2 件

log Kow = 1.40

1.44

Color/FormMonoclinic prisms from alcohol
Solubility · 2 件

Slightly soluble in water. Soluble in ethanol, ethyl ether, benzene, chloroform, and dilute acid.

Soluble in hot water

DecompositionWhen heated to decomposition it emits toxic fumes of /nitrogen oxides/.
Melting Point91.5 °C
Vapor Pressure0.000138 [mmHg]
Physical DescriptionSolid; [HSDB] Yellow powder; [Alfa Aesar MSDS]
Other Experimental Properties · 2 件

UV: 3-177 (Organic Electronic Spectral Data, Phillips et al, John Wiley & Sons, New York) /Quinoline, 3-nitro/

UV: 6811 (Sadtler Research Laboratories Spectral Collection) /Quinoline, 5-nitro/

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Warning

H302 (91.1%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 45 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Hazards Summary · 1 件

Oral administration produced evidence for carcinogenicity in rats but not in hamsters; Mutagenic in Ames test; [HSDB] Causes altered sleep time and dyspnea in intraperitoneal lethal-dose studies of mice; [RTECS] A skin and strong eye irritant; [Alfa Aesar MSDS]

Toxic Combustion ProductsWhen heated to decomposition it emits toxic fumes of /nitrogen oxides/.
Hazard Classes and CategoriesAcute Tox. 4 (91.1%)

安全と保護具

Disposal Methods · 1 件

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

毒性情報

Non-Human Toxicity Excerpts · 5 件

化学と産業

用途と製造

Uses · 3 件

Used as an experimental corrosion inhibitor (e.g., in antifreezes); Not commercially produced in the US; [HSDB]

LABORATORY REAGENT

Experimental corrosion inhibitor (e.g., in antifreezes)

U.S. Production · 2 件

(1977) NOT PRODUCED COMMERCIALLY IN US

(1979) NOT PRODUCED COMMERCIALLY IN US

Methods of ManufacturingAt 0 °C, mixed acid attacks the protonated quinoline to yield a 1:1 mixture of 5-nitroquinoline... and 8-nitroquinoline... .
Formulations/Preparations98% purity
General Manufacturing InformationQuinoline, 8-nitro-: INACTIVE

応用分野

用途ビスマス定量試薬、有機合成原料。

使用8-Nitroquinoline was used to prepare furazano [3,4-h] quinoline. It was also used to synthesize corresponding 2-substituted phenoxy-6-methoxy-8-aminoquinoline.

上流・下流製品情報

上流原料

2-ニトロアニリン五酸化二ヒ素アクロレインジエチルアセタールキノリングリセロール3-ニトロベンゼンスルホン酸ナトリウム

関連反応

16 件
反応記録を作成
HRID 118050 の反応式
HRID 118050反応物として
HRID 202834 の反応式
HRID 202834反応物として
HRID 271131 の反応式
HRID 271131反応物として
HRID 351155 の反応式
HRID 351155反応物として
HRID 353358 の反応式
HRID 353358反応物として
HRID 719799 の反応式
HRID 719799反応物として
HRID 722944 の反応式
HRID 722944反応物として
HRID 883521 の反応式
HRID 883521反応物として
前へ1 / 2 ページ

化合物ノート

このページの内容基本情報名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

物理化学的性質

融点
89 · 89-91 °C (lit.)
沸点
305.12 °C · 305.12°C (rough estimate)
比重(密度)
1.219 · 1.2190 (estimate)
屈折率
1.682 · 1.6820 (rough estimate)
貯蔵温度
Sealed in dry,Room Temperature
外見
powder to crystal
酸解離定数(Pka)
1.2 · 1.20±0.17(Predicted)
色
アルコールからの単斜晶
水溶解度
エタノール、エチルエーテル、ベンゼンに溶け、冷水に溶けにくい。
BRN
135178 · 135178
InChI
InChI=1S/C9H6N2O2/c12-11(13)8-5-1-3-7-4-2-6-10-9(7)8/h1-6H
InChIKey
OQHHSGRZCKGLCY-UHFFFAOYSA-N
SMILES
N1C2C(=CC=CC=2[N+]([O-])=O)C=CC=1
CAS データベース
607 · 607-35-2(CAS DataBase Reference)
NISTの化学物質情報
8 · 8-Nitro quinoline(607-35-2)
EPAの化学物質情報
8 · Quinoline, 8-nitro- (607-35-2)

化学的性質

化学的特性white to light yellow crystal powder

8-NITROQUINOLINE WAS ADDED TO DIET OF SPRAGUE-DAWLEY RATS FOR 48 WK. SQUAMOUS CELL CARCINOMAS OF UPPER DIGESTIVE TRACT OCCURRED. CARCINOMA OF FORESTOMACH OCCURRED IN 3 OF 11 (27.3%) RATS IN 2500 PPM GROUP & 7 OF 35 (20.0%) RATS IN 1000 PPM GROUP.

Reversibility of forestomach lesions induced by genotoxic and non-genotoxic carcinogens was compared histopathologically. Groups of 30 to 33 male F344 rats were given dietary 0.1% 8-nitroquinoline, dietary 0.4-0.2% 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide, an intragastric dose of 20 mg/kg body weight N-methyl-N'-nitro-N-nitrosoguanidine once a week, or 20 ppm N-methylnitrosourethane in the drinking water as a genotoxic carcinogen, or 2% butylated hydroxyanisole, 2% caffeic acid, 2% sesamol or 2% 4-methoxyphenol in the diet as a non-genotoxic carcinogen for 24 weeks. Ten or 11 rats in each group were killed at week 24. Half of the remainder were maintained on basal diet alone for an additional 24 weeks and the other half were given the same chemical for 48 weeks, and then killed. Forestomach lesions induced by genotoxic carcinogens did not regress after removal of carcinogens. In contrast, simple or papillary hyperplasia (SPH), but not basal cell hyperplasia (BCH), induced by non-genotoxic carcinogens clearly regressed after cessation of insult. SPH labeling indices in the non-genotoxic carcinogen-treated cases decreased after removal of the carcinogenic stimulus whereas BCH values were low irrespective of treatment. Atypical hyperplasia (AH), observed at high incidences in rats treated with genotoxic carcinogens, was also evident in animals receiving non-genotoxic agents, even after their withdrawal, albeit at low incidences. AH labeling indices remained high even without continued insult. These results indicate that even with non-genotoxic carcinogens, heritable alterations at the DNA level could occur during strong cell proliferation and result in AH development. This putative preneoplastic lesion might then progress to produce carcinomas.

Syrian golden hamsters were administered 8-nitroquinoline, at a concentration of 0.05%, in a 10% ethanol solution as drinking water for 104 weeks. The animals were kept under observation until 112 weeks of age when the experiment was terminated. Both control and treated groups developed tumors in a pattern indistinguishable from that usually observed in Syrian golden hamsters. Thus the result of this experiment indicates that 8-nitroquinoline given orally at a concentration of 0.05% is not carcinogenic in Syrian golden hamsters.

In Ames test, the quinoline derivatives, 6-nitroquinoline (6-NQ), 8-nitroquinoline (8-NQ), 6-methylquinoline (6-NQ), 8-methylquinoline (8-MQ) and 8-hydroxyquinoline (8-HQ) are mutagenic, whereas 5,7-dibromo-quinoline (5,7-DQ) is not. These compounds were administered to groups of male and female F344 rats in their diet for 104 weeks. 8-NQ induced forestomach tumors in male and female rats: it induced squamous cell papillomas in 28 (93.3%) of 30 males and in 36 (97.3%) of 37 females, and squamous cell carcinomas in 20 (66.7%) of 30 males and 24 (64.9%) of 37 females. Thus there was no sex difference in its carcinogenicity. 6-NQ induced only focal hyperplasia of the forestomach at an incidence of 30.0% in male rats and 52.8% in female rats. These results indicate a discrepancy between the mutagenicities of quinoline derivatives and their carcinogenicities to rats: only 8-NQ was carcinogenic to F344 rats.

8-Nitroquinoline was added to the semisynthetic diet of outbred Sprague-Dawley rats for 48 weeks. Squamous cell carcinomas of the upper digestive tract (tongue and esophagus), but especially of the forestomach, occurred among the higher concentration groups. Squamous cell carcinoma of the forestomach occurred in 3 of 11 (27.3%) rats in the 2500 ppm group and 7 of 35 (20.0%) rats in the 1000 ppm group. Three cases of lung adenoma were also observed in the 2500 ppm group. Results clearly indicate that 8-nitroquinoline is carcinogenic in rats when administered orally in a semisynthetic diet.

Antidote and Emergency Treatment · 2 件

Basic treatment: Establish a patent airway. Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if necessary. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with normal saline during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool. Administer activated charcoal ... . /Aromatic hydrocarbons and related compounds/

Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious or in respiratory arrest. Positive pressure ventilation techniques with a bag valve mask device may be beneficial. Monitor cardiac rhythm and treat arrhythmias if necessary ... Start an IV with D5W /SRP: "To keep open", minimal flow rate/. Use lactated Ringer's if signs of hypovolemia are present. Watch for signs of fluid overload. Consider drug therapy for pulmonary edema ... . Treat seizures with diazepam (Valium) ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Aromatic hydrocarbons and related compounds/

安全データ

wgk
3
tsca
TSCA listed
rtecs
VC1925000
毒性
TD orl-rat: 36,400 mg/kg/2Y-C:CAR,REP CALEDQ14,115,81
hs_code
29334900
risk_code
20/21/22-36/37/38-40-68
hazard_code
Xn,Xi
hazard_note
Harmful/Irritant
safety_code
26-27-36/37/39-36
Hazard Classifications
Acute Tox. 4 DermalAcute Tox. 4 InhalationAcute Tox. 4 OralCarc. 2Eye Irrit. 2Skin Irrit. 2STOT SE 3
ストレージクラス
11 - Combustible Solids
有毒物質データの
607-35-2(Hazardous Substances Data)
炭酸ナトリウム

下流製品

7-Chloro-8-aminoquinoline5-Chloroquinolin-8-amine2,3-ジニトロ安息香酸